In order to re-purpose drugs for fast-tracking COVID-19 prophylaxis and treatments, we undertook screening of two libraries of FDA-approved drugs and natural products from APExBIO by using MLV pseudotyped with the SARS-CoV-2 S protein, with the goal of targeting the major attachment and entry steps (Supplementary Information Figure S1). The gene discussed is PROS1; the disease is COVID-19.